FNA

Paragon 28, Inc.

9.99

Top Statistics
Market Cap 836 M Forward PE -20.81 Revenue Growth 18.10 %
Current Ratio 3.50 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -22.92 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -42.33 Enterprise / Revenue 3.71 Price To Sales Trailing12 Months 3.41
Profitability
Profit Margins -22.92 % Operating Margins -13.56 %
Balance Sheet
Total Cash 39 M Total Cash Per Share 0.4680 Total Debt 111 M
Total Debt To Equity 80.05 Current Ratio 3.50 Book Value Per Share 1.67
All Measures
Short Ratio 627.00 % Message Board Id finmb_142374591 Fax 888 728 1220
Shares Short Prior Month 6 M Return On Equity -0.3371 City Englewood
Uuid 6b6bb3cf-e2b1-3e78-8329-7225a8bfa2ba Previous Close 9.98 First Trade Date Epoch Utc 1 B
Book Value 1.67 Beta 1.01 Total Debt 111 M
Volume 309309 Price To Book 5.99 Fifty Two Week Low 4.65
Total Cash Per Share 0.4680 Total Revenue 244 M Shares Short Previous Month Date 1 B
Target Median Price 13.50 Audit Risk 2 Max Age 86400
Recommendation Mean 1.43 Sand P52 Week Change 0.3133 Operating Margins -13.56 %
Target Mean Price 14.33 Net Income To Common -56149000 Ask 10.40
Short Percent Of Float 0.0962 Implied Shares Outstanding 83 M Last Fiscal Year End 1 B
Trailing Peg Ratio None Average Daily Volume10 Day 820130 Average Volume10days 820130
Total Cash 39 M Next Fiscal Year End 1 B Revenue Per Share 2.95
Held Percent Insiders 0.4056 Ebitda Margins -8.76 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Share Holder Rights Risk 5
Regular Market Previous Close 9.98 Target Low Price 12.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 6.89 Open 9.95 Free Cashflow -29193750
State CO Dividend Yield 0.00 % Return On Assets -0.0839
Time Zone Short Name EST Board Risk 5 Trailing Eps -0.6700
Day Low 9.81 Address1 14445 Grasslands Drive Shares Outstanding 83 M
Compensation Risk 7 Price Hint 2 Target High Price 20.00
Website https://paragon28.com 52 Week Change -0.0959 Average Volume 564989
Forward Eps -0.4700 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 150.70 % Is_sp_500 False Regular Market Day High 10.05
Profit Margins -22.92 % Debt To Equity 80.05 Fifty Two Week High 14.79
Day High 10.05 Shares Short 4 M Regular Market Open 9.95
Industry Key medical-devices Bid 9.94 Earnings Growth 0.00 %
Enterprise To Revenue 3.71 Revenue Growth 18.10 % Shares Percent Shares Out 0.0539
Operating Cashflow -40242000 Currency USD Time Zone Full Name America/New_York
Market Cap 836 M Is_nasdaq_100 False Zip 80112
Quote Type EQUITY Industry Medical Devices Long Name Paragon 28, Inc.
Overall Risk 5 Regular Market Day Low 9.81 Held Percent Institutions 0.6095
Current Price 9.99 Enterprise To Ebitda -42.33 Financial Currency USD
Current Ratio 3.50 Gross Margins 77.51 % Industry Disp Medical Devices
Number Of Analyst Opinions 6 Country United States Float Shares 39 M
Two Hundred Day Average 8.31 Governance Epoch Date 1 B Enterprise Value 908 M
Price To Sales Trailing12 Months 3.41 Forward PE -20.81 Regular Market Volume 309309
Ebitda -21469000 Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally.

It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.

The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis.

In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot.

Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application.

Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments.

The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors.

Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.